Literature DB >> 26497539

Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.

Ingrid Reverte, Fiona Peris-Sampedro, Pia Basaure, Leticia Campa, Cristina Suñol, Margarita Moreno, José Luis Domingo, Maria Teresa Colomina.   

Abstract

RATIONALE: The apolipoprotein E (apoE) genotype influences cognitive performance in humans depending on age and sex. While the detrimental role of the apoE4 isoform on spatial learning and memory has been well-established in humans and rodents, less is known on its impact on the executive functions.
OBJECTIVES: We aimed to evaluate the effect of apoE isoforms (apoE2, apoE3, apoE4) on visuospatial attention and inhibitory control performance in female transgenic mice, and to determine the neurochemical and neuropharmacological basis of this potential relationship.
METHODS: Female mice carrying apoE2, apoE3, and apoE4 were trained in the five-choice serial reaction time task (5-CSRTT). Upon a stable performance, we manipulated the inter-trial interval and the stimulus duration to elicit impulsive responding and engage attention respectively. We further performed a pharmacological challenge by administering cholinergic and GABAergic agents. Finally, we analyzed the levels of brain amino acids and monoamines by using reversed phase high-performance liquid chromatography (HPLC).
RESULTS: ApoE4 mice showed a deficient inhibitory control as revealed by increased perseveration and premature responding. When attention was challenged, apoE4 mice also showed a higher drop in accuracy. The adverse effect of scopolamine on the task was attenuated in apoE4 mice compared to apoE2 and apoE3. Furthermore, apoE4 mice showed less dopamine in the frontal cortex than apoE2 mice.
CONCLUSIONS: We confirmed that the apoE genotype influences attention and inhibitory control in female transgenic mice. The influence of apoE isoforms in the brain neuromodulatory system may explain the cognitive and behavioral differences attributable to the genotype.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26497539     DOI: 10.1007/s00213-015-4113-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  85 in total

1.  Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene.

Authors:  P M Greenwood; T Sunderland; J L Friz; R Parasuraman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease.

Authors:  Carsten Eggers; Karl Herholz; Elke Kalbe; Wolf-Dieter Heiss
Journal:  Neurosci Lett       Date:  2006-09-25       Impact factor: 3.046

3.  Working memory and apolipoprotein E: what's the connection?

Authors:  V M Rosen; J L Bergeson; K Putnam; A Harwell; T Sunderland
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

4.  Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study.

Authors:  P M Greenwood; Chantal Lambert; Trey Sunderland; Raja Parasuraman
Journal:  Neuropsychology       Date:  2005-03       Impact factor: 3.295

Review 5.  The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.

Authors:  Natalia Del Campo; Samuel R Chamberlain; Barbara J Sahakian; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2011-05-06       Impact factor: 13.382

6.  Isoform-specific effects of apolipoprotein E on cognitive performance in targeted-replacement mice overexpressing human APP.

Authors:  T J Kornecook; A P McKinney; M T Ferguson; J-C Dodart
Journal:  Genes Brain Behav       Date:  2009-10-08       Impact factor: 3.449

7.  Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study.

Authors:  Nunzio Pomara; Lisa M Willoughby; Keith Wesnes; John J Sidtis
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

8.  Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949).

Authors:  G Davies; N Armstrong; J C Bis; J Bressler; V Chouraki; S Giddaluru; E Hofer; C A Ibrahim-Verbaas; M Kirin; J Lahti; S J van der Lee; S Le Hellard; T Liu; R E Marioni; C Oldmeadow; I Postmus; A V Smith; J A Smith; A Thalamuthu; R Thomson; V Vitart; J Wang; L Yu; L Zgaga; W Zhao; R Boxall; S E Harris; W D Hill; D C Liewald; M Luciano; H Adams; D Ames; N Amin; P Amouyel; A A Assareh; R Au; J T Becker; A Beiser; C Berr; L Bertram; E Boerwinkle; B M Buckley; H Campbell; J Corley; P L De Jager; C Dufouil; J G Eriksson; T Espeseth; J D Faul; I Ford; R F Gottesman; M E Griswold; V Gudnason; T B Harris; G Heiss; A Hofman; E G Holliday; J Huffman; S L R Kardia; N Kochan; D S Knopman; J B Kwok; J-C Lambert; T Lee; G Li; S-C Li; M Loitfelder; O L Lopez; A J Lundervold; A Lundqvist; K A Mather; S S Mirza; L Nyberg; B A Oostra; A Palotie; G Papenberg; A Pattie; K Petrovic; O Polasek; B M Psaty; P Redmond; S Reppermund; J I Rotter; H Schmidt; M Schuur; P W Schofield; R J Scott; V M Steen; D J Stott; J C van Swieten; K D Taylor; J Trollor; S Trompet; A G Uitterlinden; G Weinstein; E Widen; B G Windham; J W Jukema; A F Wright; M J Wright; Q Yang; H Amieva; J R Attia; D A Bennett; H Brodaty; A J M de Craen; C Hayward; M A Ikram; U Lindenberger; L-G Nilsson; D J Porteous; K Räikkönen; I Reinvang; I Rudan; P S Sachdev; R Schmidt; P R Schofield; V Srikanth; J M Starr; S T Turner; D R Weir; J F Wilson; C van Duijn; L Launer; A L Fitzpatrick; S Seshadri; T H Mosley; I J Deary
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

9.  Divergent effects of D₂/₃ receptor activation in the nucleus accumbens core and shell on impulsivity and locomotor activity in high and low impulsive rats.

Authors:  M Moreno; D Economidou; A C Mar; C López-Granero; D Caprioli; D E Theobald; A Fernando; A H Newman; T W Robbins; Jeffrey W Dalley
Journal:  Psychopharmacology (Berl)       Date:  2013-02-14       Impact factor: 4.530

10.  Baseline-dependent effects of cocaine pre-exposure on impulsivity and D2/3 receptor availability in the rat striatum: possible relevance to the attention-deficit hyperactivity syndrome.

Authors:  Daniele Caprioli; Young T Hong; Stephen J Sawiak; Valentina Ferrari; David J Williamson; Bianca Jupp; T Adrian Carpenter; Franklin I Aigbirhio; Barry J Everitt; Trevor W Robbins; Tim D Fryer; Jeffrey W Dalley
Journal:  Neuropsychopharmacology       Date:  2013-02-11       Impact factor: 7.853

View more
  4 in total

Review 1.  Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?

Authors:  Jennifer N K Nyarko; Maa O Quartey; Glen B Baker; Darrell D Mousseau
Journal:  Can J Psychiatry       Date:  2018-04-23       Impact factor: 4.356

2.  Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study.

Authors:  Ashish Kumar Gupta; Komal Rani; Surabhi Swarnkar; Gaurav Khunger Kumar; Mohd Imran Khan; Ruchika Pokhriyal; Domada Ratna Kumar; Vinay Goyal; Manjari Tripathi; Rishab Gupta; Rakesh Kumar Chadda; Perumal Vanamail; Gururao Hariprasad
Journal:  J Cent Nerv Syst Dis       Date:  2018-10-09

3.  The Virtual-Environment-Foraging Task enables rapid training and single-trial metrics of attention in head-fixed mice.

Authors:  Martha N Havenith; Peter M Zijderveld; Sabrina van Heukelum; Shaghayegh Abghari; Jeffrey C Glennon; Paul Tiesinga
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

4.  Neonatal 6-OHDA lesion model in mouse induces Attention-Deficit/ Hyperactivity Disorder (ADHD)-like behaviour.

Authors:  Otmane Bouchatta; Houria Manouze; Rabia Bouali-Benazzouz; Nóra Kerekes; Saadia Ba-M'hamed; Pascal Fossat; Marc Landry; Mohamed Bennis
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.